1.Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renalprognosis in patients with diabetic nephropathy
Taeyeong KIM ; Yooujin KWAK ; Jun Young LEE ; Hanwul SHIN ; Jae Seok KIM ; Jae Won YANG ; Minseob EOM
Kidney Research and Clinical Practice 2022;41(5):545-555
Diabetic nephropathy (DN) accounts for approximately half of all cases of chronic kidney disease (CKD) and end-stage kidney disease worldwide. The Renal Pathology Society (RPS) classification has been used to predict the renal prognosis in DN. In 2018, the Japanese Renal Pathology Society (JRPS) proposed a comprehensive classification system that included pathological changes in the kidney. The clinical significance of the JRPS classification system was comparatively evaluated in the present study. Methods: A total of 93 cases diagnosed with DN from 2009 to 2019 were enrolled. JRPS scores (J-scores) were calculated by scoring the pathological factors in the JRPS classification system and comparing them with clinical parameters. Results: Most pathological factors constituting the J-score were significantly correlated with clinical factors. Laminated nodules were inversely correlated with estimated glomerular filtration rate. After adjusting for age, sex, body mass index, hemoglobin A1c, diabetes duration, and hypertension, CKD stage was significantly correlated with JRPS grade, nodular lesions, and exudative lesions in the multivariate logistic regression analysis. However, receiver operating characteristic curve analysis revealed that the J-score (area under the curve [AUC] = 0.639) had lower clinical significance than the traditional RPS classification system (AUC = 0.675). Conclusion: The JRPS classification can more comprehensively reflect renal changes than the RPS classification and is correlated with renal survival. When creating a new pathological classification, arteriolar hyalinosis should not be included, whereas laminated nodules should be included.
2.Chronic intractable diarrhea caused by gastrointestinal mastocytosis.
Hyungil SEO ; Sang Hyoung PARK ; Jeong Sik BYEON ; Chang Gok WOO ; Seung Mo HONG ; Kiju CHANG ; Hoonsub SO ; Minseob KWAK ; Wan Soo KIM ; Jeong Mi LEE ; Dong Hoon YANG ; Kyung Jo KIM ; Byong Duk YE ; Seung Jae MYUNG ; Suk Kyun YANG
Intestinal Research 2016;14(3):280-284
As mast cells have been highlighted in the pathogenesis of diarrhea-predominant irritable bowel syndrome, a new term "mastocytic enterocolitis" was suggested by Jakate and colleagues to describe an increase in mucosal mast cells in patients with chronic intractable diarrhea and favorable response to treatment with antihistamines. Although it is not an established disease entity, two cases have been reported in the English medical literature. Here, for the first time in Asia, we report another case of chronic intractable diarrhea caused by gastrointestinal mastocytosis. The patient was a 70-year-old male with chronic intractable diarrhea for 3 months; the cause of the diarrhea remained obscure even after exhaustive evaluation. However, biopsy specimens from the jejunum were found to have increased mast cell infiltration, and the patient was successfully treated with antihistamines.
Aged
;
Asia
;
Biopsy
;
Diarrhea*
;
Histamine Antagonists
;
Humans
;
Irritable Bowel Syndrome
;
Jejunum
;
Male
;
Mast Cells
;
Mastocytosis*